최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기藥劑學會誌 = Journal of Korean pharmaceutical sciences, v.36 no.3, 2006년, pp.175 - 184
최한곤 (영남대학교 약학대학) , 유봉규 (영남대학교 약학대학) , 이종달 (영남대학교 약학대학) , 김정애 (영남대학교 약학대학) , 권태협 (영남대학교 약학대학) , 우종수 (영남대학교 약학대학) , 용철순 (영남대학교 약학대학)
Poly(D,L-lacic acid)(PLA) microshperes containing loazepam were prepared by a solvent-emulsion evaporation method and their release patterns were investigated in vitro. Various batches of microspheres with different size and drug content were obtained by changing the ratio of lorazepam to PLA, PLA c...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Y.W. Chien (Ed.), Novel Drug Delivery Systems, Marcel Dekker, New York, U.S.A,1992
J.R. Robinson (Ed.), Sustained and Controlled Release Drug Delivery Systems, Marcel Dekker, New York, U.S.A., 1978
P. Johnson and J.G. Lloyed-Jones (Eds.), Drug Delivery Systems: Fundamentals and Techniques, Ellis Horwood, England Chichester, 1987
B. Conti, F. Pavanetto and I. Genta, Use of polylactic acid for the preperation of microparticulate drug delivery system, J. Microencapsulation, 9, 153-166 (1992)
?R.J. Linhardt, Biodegradable polymers for controlled release of drugs: In Controlled Release of Drugs: Polymers and Aggregate Systems, M. Rosoff (Ed.), VCH Publishers, New York, U.S.A, pp. 53-96, (1988)
M. Chasin and R. Langer (Eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, U.S.A., 1990
T. Kawaguchi, A Tsugane, K. Higashide, H. Endoh, H. Kanno, T. Seki, K. Juni, S. Fukushima and M. Nakino, Control of drug release with a combination of prodrug and polymer matrix, J. Pharm. Sci., 81, 508-512 (1992)
C.G Pitt, M.M. Gratzl, A.R. Jeffcoat, R. Zweidinger and A. Schindler, Sustained drug delivery systems, J. Pharm. Sci. 68, 1534-1538 (1979)
A. Schindler, R. Jeffcoat, G.L. Kimmel, C.G. Pitt, M.E. Wall and R. Zweidinger (Eds.), Contemporary Topics in Polymer Science, Plenum Press, New York, U.S.A, pp. 251-286 (1977)
D.L. Wise, T.D. Fellmann, J.E. Sanderson and R.L. Wentworth (Eds.), Lactic-Glycolic Acid Polymers in Drug Carriers in Biology and Medicine, Academic Press, Orlando, Fla., pp. 237-270 (1979)
L.R. Beck, D.R. Cowsar, D.H. Lewis, R.J. Cosgrove, C.T. Riddle, S.L. Lowry and T. Epperly, A new long-acting injectable microcapsule system for the administration of progesterone, Fertility and Sterility, 31, 545-551 (1979)
L.R. Beck, C.E. Flowers, V.Z. Pope, W.H. Wilborn and T.R. Tice, Clinical evaluation of improved injectable microcapule contraceptive system, Am. J. Obstet. Gynecol., 147, 815-821 (1983)
H. Endoh, T. Kawaguchi, T. Seki, T. Hasegawa and K. Juni, Controlled release of 5-Fluoro-2-deoxyuridine by the combination of prodrug and polymer matrix, Chem. Pharm. Bull., 39, 458-464 (1991)
K. Juni, J. Ogata, M. Nakano, T. Ichihara, K. Mori and M. Akagi, Preparation and evaluation in vitro of polylactic acid micropsheres containing doxorubicin, Chem. Pharm. Bull., 33, 313-318 (1985)
G. Spenlehauer, M. Veillard and J.P. Benoit, Formation and characterization of cisplatin loaded poly(d,1-lactide) microspheres for chemoembolization, J. Pharm. Sci., 75, 750-755 (1986)
J.H.P. Woodland and S. Yolles, Long-acting delivery systems for narcotic antagonists, J. Med. Chem., 16, 897-901 (1973)
N. Wakiyama, K. Juni and M. Nakano, Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics, Chem. Pharm. Bull., 29, 3363-3368 (1981)
N. Wakiyama, K. Juni and M. Nakano, Preparation and evaluation in vitro of polylactic acid microspheres containing dibucaine, Chem. Pharm. Bull., 30, 3719-3727 (1982)
A.K. Kwong, S. Chou, A.M. Sun, M.V. Sefton and M.F.A. Goosen, In vitro and in vivo release of insulin from polyl (actic acid) microbeads and pellets, J. Controlled Release, 4, 47-62 (1986)
Y. Ogawa, H. Okada, M. Yamamoto and Y. Shimamoto, In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic!glycolic) acids in vitro degradation ofthese polymers, Chem. Pharm. Bull., 36, 2576-2581 (1988)
Y. Ogawa, H. Okada, T. Heya and Y. Shimamoto, Controlled release of LHRH agonists, leuprolide acetate, from micro- capsules: Serum drug level profiles and pharmacological effects in animals, J. Pharm. Pharmacol., 41, 439-444 (1989)
I. Yamakawa, Y. Tsushima, R. Machida and S. Watanabe, In vitro and in vivo release of poly(DL-lactic acid) micro- spheres containing neurotensin analogue prepared by novel oil-in water solvent evaporation method, J. Pharm. Sci., 81, 808-811 (1992)
I. Yamakawa, Y. Tsushima, R. Machida and S. Watanabe, Preparation ofneurotensin analogue-containing poly(DL-lactic acid) microsperes formed by oil-in water solvent evaporation, J. Pharm. Sci., 81, 899-903 (1992)
B.J.A. Furr and F.G. Hutchinson, A biodegradable delivery system for peptides: Preclinical experience with the gona- dotrophin- releasing hormone agonist $Zoladex^{R}$ ', J. Controlled Release, 21, 117-128 (1992)
F.G. Hutchinson and B.J.A. Furr, Biodegradable polymer systems for the sustained release of polypeptides, J. Controlled Release, 13, 279-294 (1990)
K. Suzuki and J.C. Price, Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly (d,l-lactide), J. Pharm. Sci., 74, 21-24 (1985)
J. Dreyfus, J.J. Ross and B.C. Schreiber, Excretion and biotransformation of the enanthate ester of $fluphenazine-^{14}C$ by the dog, J. Pharm. Sci., 60, 829-833 (1971)
S.M. Li, H. Garreau and M. Vert, Structure-property relationships in the case of the degradation of massive aliphatic poly-( $\alpha$ -hydroxy acids) ill aqueous media, part 1: poly(DL-lactic acid), J. Materi. Sci.; Materials in medicine, 1, 123-130 (1990)
K. Makino, M. Arakawa and T. Kondo, Preparation and in vitro degradation properties of polylactide microcapsules, Chem. Pharm. Bull., 33, 1195-1201 (1985)
J. Claassen, L.J. Hirsch and S.A. Mayer, Treatment of status epilepticus: A survey ofneurologists, J. Neurological Sci., 211, 37-41 (2003)
J.-Y. Chung, J.-Y. Cho, K.-S. Yu, J.-R. Kim, H.-R. Jung, K-S. Lim, I.-J. Jang and S.-G Shin, Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers, Clinical Pharmacology & Therapeutics, 77, 486-494 (2005)
G.L. Klerman, Overview of the cross-national collaborative panic study, Arch. Gen. Psychiatry, 45, 407-412 (1988)
Y.W. Chien (Ed.), Novel Drug Delivery Systems, Marcel Dekker, New York, U.S.A., pp. 465-545 (1982)
S.N. Muchohi, K Obiero, G.O. Kokwaro, B.R. Ogutu, I.M. Githiga, G. Edwards and C.R.J.C. Newton, Determination of lorazepam in plasma from children by high-performance liquid chromatography with UV detection, Journal of Chromatography B, 824, 333-340 (2005)
X.-P. Lee, T. Kumazawa, J. Sato, Y. Shoji, C. Hasegawa, C. Karibe, T. Arinobu, H. Seno and K Sato, Simple method for the determination ofbenzodiazepines in human body fluids by high-performance liquid chromatography-mass spectrometry, Analytica Chimica Acta, 492, 223-231 (2003)
H. Zhu and J. Luo, A fast and sensitive liquid chromatographic- tandem mass spectrometric method for assay of lorazepam and application to pharmacokinetic analysis, J. Pharmaceutical and Biomedical Analysis, 39, 268-274 (2005)
D.L. Thies and P.B. Bowman, Development of liquid chromatographic method for the determination of triazolo-benzodiazepines, J. Chromato., 268, 92-98 (1983)
J. Heller, Biodegradable polymers in controlled drug delivery, CRC Crit. Rev. Ther. Drug. Carrier Systems, 1, 39-90 (1984)
C. Sturesson, J. Carlfors, K Edsman and M. Andersson, Preparation of biodegradable poly(lactic-co-glycolic)acid microspheres and their in vitro release of timolol maleate, Int. J. Pharm., 89, 235-244 (1993)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.